Representative image NEW DELHI: In a move aimed at speeding up medical research and reducing delays in clinical trials, the Indian Council of Medical Research (ICMR) has introduced new guidelines allowing a single ethics committee to clear multicentre health studies conducted across different hospitals and institutions in India.At present, every hospital or institution participating in a multicentre study separately reviews the same research proposal, often leading to months of delays, repeated paperwork and inconsistent decisions.Under the new framework, one designated “Single Ethics Committee” will review the study on behalf of all participating sites, while continuing to monitor participant safety, informed consent and adverse events across centres.ICMR said the system is expected to improve coordination, reduce duplication and help generate faster evidence for public health policy and treatment strategies.The guidelines apply to a wide range of biomedical and health research, including clinical trials involving drugs, vaccines, biologics and medical devices, as well as public health, genetic and epidemiological studies.The document stressed that participant protection would remain central to the process despite the centralised review mechanism. Ethics committees will still be required to examine local cultural sensitivities, participant safety, informed consent procedures and site-specific risks before approving studies.The guidelines also call for stronger systems to monitor serious adverse events, protocol violations and participant safety during trials.The new framework was released during the 1st ICMR Annual Clinical Trial Meet 2026, where experts also discussed reforms needed to strengthen India’s clinical research ecosystem and expand evidence-based integrative medicine research.One of the highlights of the meeting was the presentation of findings from an ICMR-CCRAS clinical trial on iron deficiency anaemia involving nearly 4,000 women aged 18-49 years.The study compared Ayurvedic formulations — Punarnavadi Mandura alone and in combination with Drakshavaleha — with standard iron-folic acid therapy over 90 days. Researchers said the Ayurvedic formulations showed therapeutic equivalence in improving haemoglobin levels and clinical outcomes.Experts at the meeting said faster and more harmonised ethical approvals could help India improve large-scale multicentre research, including studies involving underserved and geographically dispersed populations.End of ArticleFollow Us On Social MediaVideosFIR Filed Against Parambrata Chattopadhyay & Swastika Mukherjee Over 2021 Social Media PostsFIR Filed Against Parambrata Chattopadhyay & Swastika Mukherjee Over 2021 Social Media Posts“Viksit Bharat 2047 Is Our Commitment”: PM Modi Pushes Faster Governance At Key Ministers’ MeetCBI Frees UP Man In Suvendu Adhikari PA Murder Case; Raj Singh Alleges Torture, Encounter ThreatCalcutta High Court Junks Pleas On West Bengal Cattle Slaughter Rules Ahead Of Bakr Eid‘Menon’ Surname Row: VD Satheesan Faces Heat From Kerala Congress Leaders Over Oath Name ChoiceIUML And VCK To Also Join Vijay Cabinet In Tamil Nadu, Expansion Tomorrow: ReportTMC Protests Against BJP Government Over Alleged Forced Eviction Of Hawkers In BengalTamil Nadu Cabinet Expansion: Congress MLAs Get Portfolios, Governor Stops Oath Praise Of LeadersNibe Successfully Tests Vayu Astra-1 Loitering Munition In Maiden Trials123Photostories10 legal documents you must check before buying a property in IndiaNelson Mandela quotes that define courage, leadership, and resilience10 traditional Indian foods that PM Modi gifted world leaders during his 5-nation tourThe monsoon gardening mistakes attracting mosquitoes to Indian homesArt quote of the day by Marc Chagall: “Great art picks up where nature ends”The best types of exercise for lowering colon cancer riskFrom Ronit Roy, Ram Kapoor to Tejasswi Prakash and more: TV celebs who own several luxurious propertiesThought of the day inspired by the Bhagavad Gita: “The soul grows quieter when gratitude grows louder”10 unique baby boy names that begin with the letter SLove quote of the day by Maya Angelou: “First best is falling in love, second best is…”123Hot PicksBandra demolition driveIPL Schedule 2026Indian rupeeFalta VotingUK NET MigrationElon MuskTN Ministers ListTop TrendingTN Finance Minister Marie WilsonForza Horizon 6 Hakone Nanamagari TougeChristiano RonaldoPM ModiHardik PandyaJEE Advanced Response SheetIPL Orange Cap 2026Conor McGregor Net WorthNEET UG Paper LeakWest Bengal Annapurna Yojana
NEW DELHI: In a move aimed at speeding up medical research and reducing delays in clinical trials, the Indian Council of Medical Research (ICMR) has introduced new guidelines allowing a single ethics committee to clear multicentre health studies conducted across different hospitals and institutions in India.At present, every hospital or institution participating in a multicentre study separately reviews the same research proposal, often leading to months of delays, repeated paperwork and inconsistent decisions.Under the new framework, one designated “Single Ethics Committee” will review the study on behalf of all participating sites, while continuing to monitor participant safety, informed consent and adverse events across centres.ICMR said the system is expected to improve coordination, reduce duplication and help generate faster evidence for public health policy and treatment strategies.The guidelines apply to a wide range of biomedical and health research, including clinical trials involving drugs, vaccines, biologics and medical devices, as well as public health, genetic and epidemiological studies.The document stressed that participant protection would remain central to the process despite the centralised review mechanism. Ethics committees will still be required to examine local cultural sensitivities, participant safety, informed consent procedures and site-specific risks before approving studies.The guidelines also call for stronger systems to monitor serious adverse events, protocol violations and participant safety during trials.The new framework was released during the 1st ICMR Annual Clinical Trial Meet 2026, where experts also discussed reforms needed to strengthen India’s clinical research ecosystem and expand evidence-based integrative medicine research.One of the highlights of the meeting was the presentation of findings from an ICMR-CCRAS clinical trial on iron deficiency anaemia involving nearly 4,000 women aged 18-49 years.The study compared Ayurvedic formulations — Punarnavadi Mandura alone and in combination with Drakshavaleha — with standard iron-folic acid therapy over 90 days. Researchers said the Ayurvedic formulations showed therapeutic equivalence in improving haemoglobin levels and clinical outcomes.Experts at the meeting said faster and more harmonised ethical approvals could help India improve large-scale multicentre research, including studies involving underserved and geographically dispersed populations.